Emily Rollins, Director at Dolby Laboratories, Inc. (DLB), sold 1,000 shares at $84.90 ($85K) on 2025-01-30, disclosed to the SEC on 2025-02-03.
Scheduled sale ($85k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| DLB | SELL | 2026-04-03 | $60K | — | Filing → |
| XMTR | SELL | 2026-01-06 | $124K | — | Filing → |
| XMTR | SELL | 2025-11-12 | $68K | — | Filing → |